Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for CRL

Stock Name	Creightons Plc
Ticker	CRL(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB0002341666
LEI	213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen: Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO: (RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69: Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy: Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.: Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL): Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL): Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL): Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price: In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts: Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL): Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades: Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.: Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications: The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL): Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL): Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL): Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL): Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares Healthcare Innovation UCITS ETF USD (Acc) CRL holdings

Date	Number of CRL Shares Held	Base Market Value of CRL Shares	Local Market Value of CRL Shares	Change in CRL Base Value	Current Price per CRL Share Held	Previous Price per CRL Share Held
2025-11-11 (Tuesday)	60,041	USD 10,417,114	USD 10,417,114	USD 271,986	USD 173.5	USD 168.97
2025-11-10 (Monday)	60,041	USD 10,145,128	USD 10,145,128	USD 55,238	USD 168.97	USD 168.05
2025-11-07 (Friday)	60,041	USD 10,089,890	USD 10,089,890	USD -169,916	USD 168.05	USD 170.88
2025-11-06 (Thursday)	60,041	USD 10,259,806	USD 10,259,806	USD 190,930	USD 170.88	USD 167.7
2025-11-05 (Wednesday)	60,041	USD 10,068,876	USD 10,068,876	USD -609,416	USD 167.7	USD 177.85
2025-11-04 (Tuesday)	60,041	USD 10,678,292	USD 10,678,292	USD -60,641	USD 177.85	USD 178.86
2025-11-03 (Monday)	60,041	USD 10,738,933	USD 10,738,933	USD -72,650	USD 178.86	USD 180.07
2025-10-31 (Friday)	60,041	USD 10,811,583	USD 10,811,583	USD 57,639	USD 180.07	USD 179.11
2025-10-30 (Thursday)	60,041	USD 10,753,944	USD 10,753,944	USD -62,442	USD 179.11	USD 180.15
2025-10-29 (Wednesday)	60,041	USD 10,816,386	USD 10,816,386	USD -467,119	USD 180.15	USD 187.93
2025-10-28 (Tuesday)	60,041	USD 11,283,505	USD 11,283,505	USD -441,301	USD 187.93	USD 195.28
2025-10-27 (Monday)	60,041	USD 11,724,806	USD 11,724,806	USD -105,673	USD 195.28	USD 197.04

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE00BYZK4776

Show aggregate share trades of CRL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -508 197.040 199.660 199.398 GBX -101,294 159.38 Loss of -20,327 on sale
2025-09-16 BUY 501 151.600 152.930 152.797 GBX 76,551 158.32
2025-09-11 BUY 252 159.740 159.780 159.776 GBX 40,264 158.31
2025-07-08 SELL -252 158.390 160.000 159.839 GBX -40,279 158.37 Loss of -371 on sale
2025-06-24 SELL -253 148.400 149.680 149.552 GBX -37,837 158.71 Profit of 2,317 on sale
2025-06-23 SELL -253 147.380 148.320 148.226 GBX -37,501 158.79 Profit of 2,673 on sale
2025-06-20 SELL -3,419 147.450 147.740 147.711 GBX -505,024 158.88 Profit of 38,171 on sale
2025-06-11 SELL -266 151.110 154.430 154.098 GBX -40,990 159.44 Profit of 1,420 on sale
2025-05-30 SELL -266 135.630 136.940 136.809 GBX -36,391 160.57 Profit of 6,322 on sale
2025-05-21 BUY 266 134.980 141.710 141.037 GBX 37,516 162.03
2025-05-14 SELL -1,596 138.950 146.430 145.682 GBX -232,508 162.80 Profit of 27,319 on sale
2025-04-30 SELL -266 118.620 118.690 118.683 GBX -31,570 166.12 Profit of 12,617 on sale
2025-04-28 SELL -266 115.080 117.160 116.952 GBX -31,109 167.12 Profit of 13,346 on sale
2025-04-25 SELL -266 114.660 115.250 115.191 GBX -30,641 167.66 Profit of 13,957 on sale
2025-04-11 SELL -1,602 99.750 101.360 101.199 GBX -162,121 173.08 Profit of 115,149 on sale
2025-04-08 SELL -801 123.610 137.960 136.525 GBX -109,357 174.88 Profit of 30,720 on sale
2025-04-07 BUY 762 134.070 139.160 138.651 GBX 105,652 175.35
2025-03-31 SELL -524 150.520 153.820 153.490 GBX -80,429 176.80 Profit of 12,214 on sale
2025-03-21 SELL -524 167.280 167.940 167.874 GBX -87,966 178.03 Profit of 5,321 on sale
2025-03-12 SELL -262 170.590 171.190 171.130 GBX -44,836 178.70 Profit of 1,984 on sale
2025-02-28 SELL -262 165.310 165.820 165.769 GBX -43,431 180.05 Profit of 3,740 on sale
2025-02-25 BUY 262 167.100 172.430 171.897 GBX 45,037 180.74
2025-02-20 SELL -262 162.250 168.020 167.443 GBX -43,870 181.58 Profit of 3,705 on sale
2025-02-19 BUY 524 165.000 166.440 166.296 GBX 87,139 181.89
2025-02-18 BUY 262 154.390 155.690 155.560 GBX 40,757 182.41
2024-12-30 BUY 463 183.420 185.100 184.932 GBX 85,624 193.99
2024-12-06 SELL -258 191.810 195.370 195.014 GBX -50,314 193.70 Loss of -338 on sale
2024-12-04 SELL -258 199.350 201.420 201.213 GBX -51,913 193.58 Loss of -1,970 on sale
2024-12-03 SELL -516 199.300 201.120 200.938 GBX -103,684 193.37 Loss of -3,907 on sale
2024-11-22 BUY 443 195.770 198.180 197.939 GBX 87,687 191.33
2024-11-21 SELL -256 194.190 194.880 194.811 GBX -49,872 191.18 Loss of -930 on sale
2024-11-20 SELL -255 187.900 188.320 188.278 GBX -48,011 191.36 Profit of 786 on sale
2024-11-19 BUY 322 186.100 188.380 188.152 GBX 60,585 191.67
2024-11-18 SELL -1,016 187.500 187.930 187.887 GBX -190,893 191.93 Profit of 4,108 on sale
2024-11-12 SELL -254 215.940 221.600 221.034 GBX -56,143 190.33 Loss of -7,799 on sale
2024-11-07 SELL -254 210.290 217.600 216.869 GBX -55,085 186.87 Loss of -7,621 on sale
2024-11-05 SELL -508 188.680 189.180 189.130 GBX -96,078 184.22 Loss of -2,496 on sale
2024-10-28 SELL -254 186.520 188.000 187.852 GBX -47,714 186.49 Loss of -345 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-508	197.040	199.660	199.398	GBX -101,294	159.38 Loss of -20,327 on sale
2025-09-16	BUY	501	151.600	152.930	152.797	GBX 76,551	158.32
2025-09-11	BUY	252	159.740	159.780	159.776	GBX 40,264	158.31
2025-07-08	SELL	-252	158.390	160.000	159.839	GBX -40,279	158.37 Loss of -371 on sale
2025-06-24	SELL	-253	148.400	149.680	149.552	GBX -37,837	158.71 Profit of 2,317 on sale
2025-06-23	SELL	-253	147.380	148.320	148.226	GBX -37,501	158.79 Profit of 2,673 on sale
2025-06-20	SELL	-3,419	147.450	147.740	147.711	GBX -505,024	158.88 Profit of 38,171 on sale
2025-06-11	SELL	-266	151.110	154.430	154.098	GBX -40,990	159.44 Profit of 1,420 on sale
2025-05-30	SELL	-266	135.630	136.940	136.809	GBX -36,391	160.57 Profit of 6,322 on sale
2025-05-21	BUY	266	134.980	141.710	141.037	GBX 37,516	162.03
2025-05-14	SELL	-1,596	138.950	146.430	145.682	GBX -232,508	162.80 Profit of 27,319 on sale
2025-04-30	SELL	-266	118.620	118.690	118.683	GBX -31,570	166.12 Profit of 12,617 on sale
2025-04-28	SELL	-266	115.080	117.160	116.952	GBX -31,109	167.12 Profit of 13,346 on sale
2025-04-25	SELL	-266	114.660	115.250	115.191	GBX -30,641	167.66 Profit of 13,957 on sale
2025-04-11	SELL	-1,602	99.750	101.360	101.199	GBX -162,121	173.08 Profit of 115,149 on sale
2025-04-08	SELL	-801	123.610	137.960	136.525	GBX -109,357	174.88 Profit of 30,720 on sale
2025-04-07	BUY	762	134.070	139.160	138.651	GBX 105,652	175.35
2025-03-31	SELL	-524	150.520	153.820	153.490	GBX -80,429	176.80 Profit of 12,214 on sale
2025-03-21	SELL	-524	167.280	167.940	167.874	GBX -87,966	178.03 Profit of 5,321 on sale
2025-03-12	SELL	-262	170.590	171.190	171.130	GBX -44,836	178.70 Profit of 1,984 on sale
2025-02-28	SELL	-262	165.310	165.820	165.769	GBX -43,431	180.05 Profit of 3,740 on sale
2025-02-25	BUY	262	167.100	172.430	171.897	GBX 45,037	180.74
2025-02-20	SELL	-262	162.250	168.020	167.443	GBX -43,870	181.58 Profit of 3,705 on sale
2025-02-19	BUY	524	165.000	166.440	166.296	GBX 87,139	181.89
2025-02-18	BUY	262	154.390	155.690	155.560	GBX 40,757	182.41
2024-12-30	BUY	463	183.420	185.100	184.932	GBX 85,624	193.99
2024-12-06	SELL	-258	191.810	195.370	195.014	GBX -50,314	193.70 Loss of -338 on sale
2024-12-04	SELL	-258	199.350	201.420	201.213	GBX -51,913	193.58 Loss of -1,970 on sale
2024-12-03	SELL	-516	199.300	201.120	200.938	GBX -103,684	193.37 Loss of -3,907 on sale
2024-11-22	BUY	443	195.770	198.180	197.939	GBX 87,687	191.33
2024-11-21	SELL	-256	194.190	194.880	194.811	GBX -49,872	191.18 Loss of -930 on sale
2024-11-20	SELL	-255	187.900	188.320	188.278	GBX -48,011	191.36 Profit of 786 on sale
2024-11-19	BUY	322	186.100	188.380	188.152	GBX 60,585	191.67
2024-11-18	SELL	-1,016	187.500	187.930	187.887	GBX -190,893	191.93 Profit of 4,108 on sale
2024-11-12	SELL	-254	215.940	221.600	221.034	GBX -56,143	190.33 Loss of -7,799 on sale
2024-11-07	SELL	-254	210.290	217.600	216.869	GBX -55,085	186.87 Loss of -7,621 on sale
2024-11-05	SELL	-508	188.680	189.180	189.130	GBX -96,078	184.22 Loss of -2,496 on sale
2024-10-28	SELL	-254	186.520	188.000	187.852	GBX -47,714	186.49 Loss of -345 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	98,139	1	131,075	74.9%
2025-09-18	62,997	2	121,436	51.9%
2025-09-17	92,129	0	727,005	12.7%
2025-09-16	115,396	12	317,673	36.3%
2025-09-15	66,356	1	151,093	43.9%
2025-09-12	77,557	0	176,817	43.9%
2025-09-11	87,999	1	204,237	43.1%
2025-09-10	122,656	0	398,564	30.8%
2025-09-09	125,402	0	471,642	26.6%
2025-09-08	178,342	0	414,729	43.0%
2025-09-05	76,264	0	192,668	39.6%
2025-09-04	94,792	0	179,533	52.8%
2025-09-03	139,646	0	216,265	64.6%
2025-09-02	112,819	30	183,910	61.3%
2025-08-29	105,965	1,040	180,206	58.8%
2025-08-28	183,971	4	248,978	73.9%
2025-08-27	71,891	0	134,034	53.6%
2025-08-26	109,853	19	166,152	66.1%
2025-08-25	147,166	23	300,781	48.9%
2025-08-22	251,126	0	414,085	60.6%
2025-08-21	102,152	0	149,376	68.4%
2025-08-20	152,721	0	215,946	70.7%
2025-08-19	118,831	0	172,887	68.7%
2025-08-18	93,028	0	164,641	56.5%
2025-08-15	96,500	1	180,165	53.6%
2025-08-14	147,952	0	251,456	58.8%
2025-08-13	820,206	0	1,075,153	76.3%
2025-08-12	299,322	0	438,699	68.2%
2025-08-11	192,917	0	365,058	52.8%
2025-08-08	92,089	66	222,128	41.5%
2025-08-07	326,647	522	550,230	59.4%
2025-08-06	532,434	7,827	888,873	59.9%
2025-08-05	283,148	6	539,938	52.4%
2025-08-04	124,111	54	248,834	49.9%
2025-08-01	162,441	300	281,622	57.7%
2025-07-31	125,648	0	228,706	54.9%
2025-07-30	115,487	0	188,121	61.4%
2025-07-29	181,159	0	275,843	65.7%
2025-07-28	198,896	49	321,941	61.8%
2025-07-25	162,642	111	293,831	55.4%
2025-07-24	385,658	456	820,472	47.0%
2025-07-23	150,650	0	346,020	43.5%
2025-07-22	205,736	26	821,853	25.0%
2025-07-21	132,794	101	445,920	29.8%
2025-07-18	93,150	207	186,542	49.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE